The authors noted that the majority of the T-cell population, especially CD4+ helper T cells, was the result of the effect of this treatment.27 However, the role of immunotherapy in the treatment of non-metastatic PCa is controversial,28 and further studies are needed on this subject. The gene discussed is CD4; the disease is posterior cortical atrophy.